ImatiniB is a chronic bone marrow leukemia (CML) adult patient with positive in Philadelphia Chromosome (Ber-abl), an acceleration period and an interferon treatment failure after the failure of the chronic period . CML is a hematopoietic stem cell disease caused by DNA abnormalities in bone marrow. DNA abnormally produces an abnormal protein, interferes with the normal production process of white blood cells in the bone marrow, which ultimately leads to a sharp increase in the number of white blood cells. CML is divided into three stages of chronic, acceleration period and period of crisis, and the average survival elbow between patients in crisis is only 2-3 months.
Chronic myeloid leukemia (PH + CML) for the treatment of Philadelphia chromosome (pH + CML) is used. Adult patients used to treat malignant gastrointestinal tumor (gist) that cannot be removed and / or transferred. Dielectric treatment of newly diagnosed Philadelphia Children patients with positive acute lymphocytic leukemia (pH + all). Adult patients for the treatment of recurrent refractory Philadelphia chromosomal positive acute lymphocytes leukemia (pH + all).
Dasatinib | AZD9291 | Lapatinib ditosylate | Erlotinib Hydrochloride |
Gefitinib | Niraparib tosylate monohydrate | Imatinib mesylate | Imatinib |
LOXO 195 | LOXO 101 | Ibrutinib | Cabozantinib Malate |
A. Customs clearance
1) By Express:
Normally there is no specical need for the recipient to clear the customs. If the customs has an objection,our rich experienced and peofessional group will help you clear the customs.
2) By Air and by Sea:
Our company will cooperate with the recipient to provide relevant file and information in the customs clearance procedure.
B. Payment
T/T,Wester Union,MoneyGram,Alibaba Trade Assurance,L/C ,Bank transfer etc.